The New Face of Business Activism
On March 9th, I accurately predicted an AbbVie Inc. (ABBV) market low in my blog, "AbbVie (ABBV): Its Now Time to Get In". This was about the lowest the stock got since October of last year. The stock went from $55.64 to close at $66.07, yesterday, just 46 days later--generating an 18.7% gain.While I realize that there are many people and events that have influenced AbbVie's climb, I maintain that I was one of the individual players involved. I wrote three, very high quality blogs in March that I believe helped persuade investors. They can be found at my blog: American Galileo. The following is a summary:
(1) "Pay your own way for a better life." In this personal, historical narrative, I explored a life that chose to stand by one's own economic productivity despite financial pressure. I showed the pride involved and ultimate triumph.
(2) "Socialist Takeover of Pharmaceutical Companies' Prices?" This blog defended property rights--specifically, the freedom of trade. I exposed the behavior of Express Scripts and appealed to the moral solution--that being to "...give up the economically devastating dream of free lunches without capitalist payment".
(3) "A Promise Kept? A Lie Made." In this blog, I took on medical "entitlements" in a way that differed from the traditional, Objectivist approach. I argued that there shouldn't even be a "sliding scale" reduction, and that all of the socialist programs are already, completely gone.
While there have been some people doing this, I envision a new career field that integrates my kind of blogging with a deeply, philosophical level of business activism. As an intellectual, I seek to team-up with the businessman in an alliance where my thought generates his profit, and his products improve my mind. Of course, it also helps that I make money directly from my market activities, as I am doing.
Paul Wharton
Objectivist Capitalist Medicine Promoter